This compound is primarily utilized in organic synthesis and pharmaceutical research as a key intermediate. Its boronic acid functional group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to form carbon-carbon bonds in the development of complex organic molecules, including drugs and agrochemicals. The cyclopentylcarbamoyl moiety enhances its potential in designing bioactive compounds, particularly in targeting specific enzymes or receptors. Researchers leverage its structural features to develop novel therapeutic agents, especially in areas like oncology and inflammation, where precise molecular interactions are critical. Additionally, its stability and reactivity profile make it suitable for use in medicinal chemistry for lead optimization and drug discovery processes.